Xiamen Amoytop Biotech Co (SHSE:688278) Total Liabilities : ¥430 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Xiamen Amoytop Biotech Co Total Liabilities?

Xiamen Amoytop Biotech Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥430 Mil.

Xiamen Amoytop Biotech Co's quarterly Total Liabilities increased from Sep. 2024 (¥418.77 Mil) to Dec. 2024 (¥497.10 Mil) but then declined from Dec. 2024 (¥497.10 Mil) to Mar. 2025 (¥429.84 Mil).

Xiamen Amoytop Biotech Co's annual Total Liabilities increased from Dec. 2022 (¥362.27 Mil) to Dec. 2023 (¥479.69 Mil) and increased from Dec. 2023 (¥479.69 Mil) to Dec. 2024 (¥497.10 Mil).

Xiamen Amoytop Biotech Co Total Liabilities Historical Data

The historical data trend for Xiamen Amoytop Biotech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiamen Amoytop Biotech Co Total Liabilities Chart

Xiamen Amoytop Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

203.95

262.92

362.27

479.69

497.10

Xiamen Amoytop Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															421.70	390.79	418.77	497.10	429.84

Xiamen Amoytop Biotech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Xiamen Amoytop Biotech Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	420.629	+	(3.268	+	73.202
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	497

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	3050.415	-	2553.316
	=	497

Xiamen Amoytop Biotech Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	345.502	+	(3.257	+	81.08
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	430

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	3179.124	-	2749.284
	=	430

Xiamen Amoytop Biotech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Xiamen Amoytop Biotech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiamen Amoytop Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiamen Amoytop Biotech Co Ltd (SHSE:688278) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.330 Wengjiao Road, Xinyang Industry Zone of Haicang, Fujian, Xiamen, CHN, 361022

Website

http://www.amoytop.com

Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.

Executives

Lan Chun	Director
Wang Jun Ye	Director

Xiamen Amoytop Biotech Co Headlines

No Headlines